Trioar
PrivateLast Round
Grant
Jul 6, 2026
Est. Valuation
$56.9M
Total Funding Raised
$53.16M
Company Overview
Trioar is a biotechnology company that develops next-generation antibody-based therapeutics, including antibody-drug conjugates (ADCs) and immuno-oncology treatments, using its proprietary TROCAD™ and TROSIG™ platform technologies.
Sector
Enterprise Software
Verticals
AR/VR Experiences, Marketing, Event Management, Content Creation
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trioar Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Trioar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 6, 2026 | ||||
| Series B | Aug 28, 2025 | ||||
| Series B | Jul 17, 2025 | ||||
| Series A | May 23, 2023 | ||||
| Pre Seed | Feb 24, 2022 | ||||
Angel | May 1, 2021 |
Trioar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Series B |
| Shinhan Venture Investment | Series B |
| KB Investment | Series B, Pre Seed, Series A |
| Woori Venture Partners Co., Ltd. | Series B |
| Kiwoom Investment | Series B, Series A |
| Hyundai Technology Investment | Series B |
| Jin & Investment Partners | Series B |
Trioar Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trioar's valuation, stock price, and market status.